They weigh up all their current & future pipeline almost daily in terms of risk/reward monetary values. I'm not really sure I feel a great desire to shed a tear for big pharma. They always seem to do alright when their results get posted at the end of each financial year. I've wrestled with the debate as to whether human medicine development/discovery is best done in this environment for a long time. And, I still haven't decided. Competition is good/healthy, but financial drive seems to be trumping the human/healing element more than ever.
In the last decade, it feels like they've spun most of the risks out to the small biotech startups, who they'll all get into a bidding war over once a potential product shows a vague shred of promise/monetary value. I'm not discounting the fact that the hills aren't littered with the hundreds of corpses of failed "promising" new biotechs/drugs they pumped hundreds of millions into for absolutely no return at all. I'm just not convinced the whole ecosystem is the best long-term strategy for human health. I guess that's what I'm really trying to say.